Skip to content
  1. Home/
  2. Latest news/
  3. What you need to know about Johnson & Johnson’s 2023 transparency report
JNJ_Microscopic_Illustration_LeukemiaWhiteBloodCells_Colorway02 Zoomed in

What you need to know about Johnson & Johnson’s 2023 transparency report

The annual report has just been released—here are key takeaways that showcase the company’s commitment to creating a more sustainable, equitable and innovative healthcare system.

Johnson & Johnson is leading the charge when it comes to reconnecting health & care—blending innovations in medicine and technology with personalized solutions that put the patient at the center.

As part of this mission to prioritize patients, the company has just released the 2023 Johnson & Johnson U.S. Pricing Transparency Report. In its eighth year, the report continues the company’s legacy of providing key data, analysis and insights that will help advance solutions to create a more sustainable, equitable and innovative healthcare system.

“At Johnson & Johnson, we take pride in pioneering cures and treatments that provide hope for patients,” says Tom Cavanaugh, Company Group Chairman, North America. “The American medical innovation ecosystem will continue advancing health more in the next decade than in the last century—as long as policies at the U.S. federal and state level put patient healthcare needs first. The eighth edition of our U.S. Pricing Transparency Report, now live, provides data and insights for a more sustainable, equitable and innovative healthcare system.”

Some key takeaways from the report:

An infographic displaying key takeaways from the J&J Innovative Medicine Transparency Report

Everything Johnson & Johnson does is guided by Our Credo, which states that the company’s first responsibility is to “the patients, doctors and nurses, to mothers and fathers and all others who use our products and services.” We believe that respect for individual patient values must be center stage in any solution and any value assessment.

More from Johnson & Johnson

Inside Johnson & Johnson’s decades-long quest to develop effective treatments for IBD

Inflammatory bowel disease doesn’t have a cure—yet. But the recent FDA approval of a promising medication is the latest in a long line of treatments from Johnson & Johnson that are helping patients with IBD.

The future of immunology

Learn about the advances Johnson & Johnson is making to potentially help treat the millions of people living with conditions in which the immune system mistakenly damages healthy cells in the body.

Using your own cells to fight cancer

Cell therapy is bringing the world one step closer to eliminating cancer. Here’s how Johnson & Johnson is moving this cutting-edge therapy forward.